Advertisement

Drug Investigation

, Volume 2, Issue 3, pp 197–199 | Cite as

Important Reduction of Ciprofloxacin Absorption by Sucralfate and Magnesium Citrate Solution

  • J. R. B. J. Brouwers
  • H. J. Van Der Kam
  • J. Sijtsma
  • J. H. Proost
Short Communication

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Brandstaetter G, Kratochvil P. Comparison of two sucralfate dosages (2g twice a day versus 1g four times a day) in duodenal ulcer. American Journal of Medicine 79 (Suppl. 2c): 36–38, 1985PubMedCrossRefGoogle Scholar
  2. Brouwers JRBJ. Pharmacokinetics of the newer fluoroquinolones. Pharmaceutisch Weekblad Scientific Edition 9 (Suppl.): S16–S22, 1987PubMedCrossRefGoogle Scholar
  3. Cannon LA, Heiselman D, Gardner W, Jones J. Prophylaxis of upper gastrointestinal tract bleeding in mechanically ventilated patients: a randomized study comparing the efficacy of sucralfate, cimetidine and antacids. Archives of Internal Medicine 147: 2101–2106, 1987PubMedCrossRefGoogle Scholar
  4. Garrelts JC, Godley PJ, Peterie JD, Gorlach EH, Yakahe CC. Sucralfate significantly reduces ciprofloxacin concentrations in serum. Antimicrobial Agents and Chemotherapy 34: 931–933, 1990PubMedCrossRefGoogle Scholar
  5. Golper TA, Harsten AI, Morthland VH, Christensen JM. Effects of antacids and dialysate dwell times on multiple-dose pharmacokinetics of oral ciprofloxacin in patients on continuous ambulatory peritoneal dialysis. Antimicrobial Agents and Chemotherapy 31: 1787–1790, 1987PubMedCrossRefGoogle Scholar
  6. Grasela TE, Schentag JJ, Sedman AJ, Wilton JH, Thomas DJ, et al. Inhibition of enoxacin absorption by antacids or ranitidine. Antimicrobial Agents and Chemotherapy 33: 615–617, 1989PubMedCrossRefGoogle Scholar
  7. Groeneveld C, Brouwers JRBJ. Quantitative determination of ofloxacin, ciprofloxacin, norfloxacin and pefloxacin in serum by high pressure liquid chromatography. Pharmaceutisch Weekblad Scientific Edition 8: 79–84, 1986PubMedCrossRefGoogle Scholar
  8. Höffken G, Lode H, Wiley R, Glatzel TD, Sievers D, et al. Pharmacokinetics and bioavailability of ciprofloxacin and ofloxacin: effects of food and antacid intake. Reviews of Infectious Diseases 10 (Suppl. 1): S138–S139, 1988Google Scholar
  9. Nix DE, Watson WA, Handy L, Frost RW, Rescott DR, et al. The effect of sucralfate pretreatment on the pharmacokinetics of ciprofloxacin. Pharmacotherapy 9: 377–380, 1989bPubMedGoogle Scholar
  10. Nix DE, Watson WA, Lener ME, et al. Effects of aluminium and magnesium antacids and ranitidine on the absorption of ciprofloxacin. Clinical Pharmacology and Therapeutics 46: 700–705, 1989aPubMedCrossRefGoogle Scholar
  11. Nix DE, Wilton JH, Ronald B, et al. Inhibition of norfloxacin absorption by antacids. Antimicrobial Agents and Chemotherapy 34: 432–434, 1990PubMedCrossRefGoogle Scholar
  12. Parpia SH, Nix DE, Hejmanowski LG, Goldstein HR, Wilton JH, et al. Sucralfate reduces the gastrointestinal absorption of norfloxacin. Antimicrobial Agents and Chemotherapy 33: 99–102, 1989PubMedCrossRefGoogle Scholar
  13. Polk RE, Healy DP, Sahai JV, Drwal L. Effect of ferrous sulfate and multivitamins with zinc on the absorption of ciprofloxacin in normal volunteers. Antimicrobal Agents and Chemotherapy 33: 1841–1844, 1989CrossRefGoogle Scholar
  14. Rubenstein E, Segev S. Drug interactions of ciprofloxacin with other non-antibiotic agents. American Journal of Medicine 82 (Suppl. 4A): 119–123, 1987Google Scholar
  15. Shiba K, Saito A, Shimada J, Hori S, Kaji M, et al. Drug interactions of fleroxacin with dried aluminium hydroxide gel and probenicid. 2nd International Symposium on New Quinolones, Geneva, 25–27 August, 1988. Abstract, p. 125, 1988Google Scholar
  16. Stroshane RM, Brown RR, Cook JA, Silverman MH. The effect of food, milk and antacid on the absorption of orally administered amifloxacin. 2nd International Symposium on New Quinolones, 25–27 August, 1988. Abstract, p. 75, 1988Google Scholar
  17. Yuk JH, Nightingale CN, Quintiliani R. Ciprofloxacin levels when receiving sucralfate. Journal of the American Medical Association 262: 901, 1989PubMedCrossRefGoogle Scholar

Copyright information

© Adis International Limited 1990

Authors and Affiliations

  • J. R. B. J. Brouwers
    • 1
  • H. J. Van Der Kam
    • 1
  • J. Sijtsma
    • 1
  • J. H. Proost
    • 2
  1. 1.Department of Clinical Pharmacy and PharmacokineticsGeneral Hospital de JongerschansHeerenveenThe Netherlands
  2. 2.University Centre for Pharmacy, Department of Pharmacology and PharmacotherapeuticsUniversity of GroningenThe Netherlands

Personalised recommendations